Vector BioPharma

Series A

Basel, SwitzerlandAug 2022

Vector BioPharma raised €29M in a Series A round in Aug 2022. The company is based in Basel, Switzerland. Data as of Nov 2026.

Amount raised

€29M

€29,168,692

Native amount

30,000,000 USD

Stage

Series A

series a

Investors

Provenance & confidence

High confidence

Amount

30,000,000 USD

ECB-at-date → €29M · rate 1.0285 on 2022-08-12

High confidence

Source

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

0 named

No investors disclosed for this round.

Date

Aug 2022

Round type

series a

Amount (EUR)

€29M

same company

This is the company's only recorded round.